{
  "id": "whipples-triad",
  "title": "Whipple’s Triad",
  "lang": "en",
  "source_lang": "en",
  "summary": "Whipple’s triad identifies a clinical hypoglycemic episode through compatible symptoms, a concurrent low plasma glucose concentration, and symptom resolution when glucose is raised.",
  "category": "health",
  "subcategory": "medicine",
  "type": "concept",
  "aliases": [
    "Whipple triad"
  ],
  "generated_at": "2026-11-05",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/whipples-triad/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/whipples-triad/",
      "json": "https://aiwiki.page/zh/whipples-triad.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Whipple’s triad is a set of three clinical findings used to establish that symptoms are attributable to hypoglycemia: symptoms or signs consistent with low blood glucose, a low plasma glucose concentration documented during those symptoms, and resolution of the symptoms after glucose is raised. It is particularly important in evaluating suspected hypoglycemic disorders in people without diabetes mellitus. The triad establishes a relationship between symptoms and low glucose; it does not identify the underlying cause."
    },
    {
      "heading": "The three components",
      "text": "Symptoms or signs compatible with hypoglycemia\n\nHypoglycemia can produce two overlapping groups of manifestations:\n\n- Autonomic symptoms, arising from physiological responses to falling glucose, include sweating, tremor, hunger, and palpitations.\n- Neuroglycopenic manifestations, resulting from inadequate glucose availability to the brain, include confusion, behavioral changes, visual disturbance, impaired coordination, seizures, and loss of consciousness.\n\nThese manifestations are not specific to hypoglycemia. Similar symptoms can occur with other illnesses, medication effects, or physiological stress. Symptoms alone therefore do not establish the diagnosis.\n\nLow plasma glucose during the episode\n\nThe glucose measurement must correspond to the symptomatic episode. A low value obtained at another time does not demonstrate that glucose caused the symptoms in question.\n\nIn adults without diabetes, a laboratory-measured plasma glucose concentration below approximately \\(55\\ \\text{mg/dL}\\), or \\(3.0\\ \\text{mmol/L}\\), is commonly used in evaluating suspected hypoglycemia. This is not a universal boundary at which every person develops symptoms. Responses vary with the circumstances, prior glucose exposure, and recurrent episodes.\n\nFor formal investigation of a hypoglycemic disorder in a person without diabetes, reliable laboratory measurement is important. Home glucose meters and continuous glucose monitoring can reveal patterns, but their accuracy is more limited at low concentrations. Continuous monitors also measure glucose in interstitial fluid rather than directly in plasma, introducing a potential time difference during rapid glucose changes.\n\nResolution after glucose is raised\n\nThe final component is disappearance of the symptoms or signs when plasma glucose rises. This temporal response strengthens the inference that inadequate glucose availability caused the episode.\n\nFeeling better after eating, without documentation of low glucose during the symptoms, does not by itself satisfy the triad. Food intake can coincide with improvement in symptoms unrelated to hypoglycemia."
    },
    {
      "heading": "Clinical role",
      "text": "Whipple’s triad helps distinguish a true hypoglycemic disorder from nonspecific symptoms or an isolated low glucose result. It is a central organizing principle in the evaluation of adults without diabetes, in whom spontaneous hypoglycemia is relatively uncommon.\n\nOnce the triad is documented, the differential diagnosis concerns why hypoglycemia occurred. Possible causes include:\n\n- Exposure to insulin or medicines that stimulate insulin secretion.\n- Endogenous excess insulin secretion, including an insulinoma.\n- Critical illness, including sepsis or severe organ dysfunction.\n- Deficiencies of hormones involved in glucose regulation.\n- Hypoglycemia following some forms of gastrointestinal surgery.\n- Certain non-islet-cell tumors.\n\nMeasurements obtained during a documented episode—such as insulin, C-peptide, ketones, and tests for insulin-releasing medicines—can help distinguish these mechanisms. Depending on the clinical setting, specialist investigations may include a supervised fast or a mixed-meal test. The triad itself neither establishes an insulinoma diagnosis nor localizes a tumor."
    },
    {
      "heading": "Interpretation and limitations",
      "text": "Diabetes-related hypoglycemia\n\nIn people treated with insulin or other glucose-lowering medicines, hypoglycemia is often recognized and managed without formal documentation of all three components. Diabetes care commonly uses \\(70\\ \\text{mg/dL}\\), or \\(3.9\\ \\text{mmol/L}\\), as an alert threshold, while values below \\(54\\ \\text{mg/dL}\\), or \\(3.0\\ \\text{mmol/L}\\), represent clinically significant biochemical hypoglycemia. These categories serve a different purpose from requiring Whipple’s triad to establish an otherwise unexplained hypoglycemic disorder.\n\nImpaired awareness and incomplete documentation\n\nRecurrent hypoglycemia may diminish warning symptoms. A person may also be unable to report symptoms during a severe episode. Consequently, absence of a fully documented triad does not prove that a low glucose concentration is harmless or that hypoglycemia did not occur.\n\nMeasurement artifacts\n\nGlucose can fall in a collected blood sample if blood cells continue consuming it before processing. Poor peripheral perfusion can also affect finger-stick measurements. Such findings must be distinguished from genuinely low circulating plasma glucose.\n\nSymptoms after meals\n\nPost-meal symptoms do not necessarily indicate “reactive hypoglycemia.” A causal connection requires the same combination of compatible symptoms, concurrent low glucose, and resolution with glucose correction. An isolated low value during a glucose challenge is not equivalent to a spontaneous symptomatic episode."
    },
    {
      "heading": "Historical background",
      "text": "The triad is named after the American surgeon Allen O. Whipple, whose work on insulin-secreting pancreatic tumors helped establish its clinical importance in the 1930s. Although initially associated with the assessment of suspected insulinoma, its application extends to the evaluation of hypoglycemia from many causes."
    }
  ],
  "links": [
    "hypoglycemia",
    "diabetes-mellitus",
    "palpitations",
    "brain",
    "diagnosis",
    "continuous-glucose-monitoring",
    "differential-diagnosis",
    "insulin",
    "sepsis"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}